-+ 0.00%
-+ 0.00%
-+ 0.00%
Avalyn Pharma CEO Lyn Baranowski Reports Sale of Common Shares Worth $1.46 Million
Share
Listen to the news
Avalyn Pharma CEO Lyn Baranowski Reports Sale of Common Shares Worth $1.46 Million
  • Avalyn Pharma CEO and director Lyn Baranowski sold 52,500 common shares on Nov. 17-18, 2026.
  • Baranowski exercised stock options for the same number of shares at $4.62 per share.
  • The sales carried weighted-average prices ranging from $27.7604 to $29.2249 per share.
  • Following the transactions, Baranowski held no common shares directly and retained 610,833 stock options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalyn Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-468543), on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending